Indefinite Delivery Contract 75D30123D15811
Award Date
12/31/22
Last Date to Order
2/28/24
Federal Agency
CDC Pittsburgh
Awardee
Glaxosmithkline, LLC
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
This multiple award IDV was issued by the Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh to procure pediatric flu vaccines for 2023-2024. Sanofi Pasteur Inc. is the prime contractor awarded under the $153.88 million potential value contract. The IDV aims to deliver pediatric flu vaccines through task orders or price lists issued against the master agreement prior to the February 2024 ordering deadline. As the CDC works to prevent pediatric...
The Indefinite Delivery Contract awarded by the Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh provides for pediatric flu vaccines for the 2023-2024 period. The multiple award contract has a potential value of $220.5 million and was awarded to Seqirus USA Inc. on December 31, 2022. The contract aims to procure pediatric flu vaccines through February 28, 2024 to support the Centers for Disease Control and Prevention's efforts in preventing the spread...
This multiple award IDV was issued by the Department of Health and Human Services Centers for Disease Control and Prevention in Pittsburgh to procure adult flu vaccines for 2023-2024. Astrazeneca Pharmaceuticals LP is the prime contractor tasked with delivering vaccines under associated task orders or price lists up to a potential value of $8.5 million by February 2024. The CDC aims to prevent the spread of influenza through this IDV. As the leading public health agency, it coordinates the...
The federal contract IDV award is for the procurement of pediatric flu vaccines by the Centers for Disease Control and Prevention (CDC) Pittsburgh, a civilian agency. The prime contractor is Glaxosmithkline, LLC, a foreign-owned, for-profit pharmaceutical company that specializes in vaccines, antiviral medications, and other medical countermeasures. The contract has a ceiling value of $182,592,000.00 and a period of performance from December 31, 2024 to February 28, 2026. It is a multiple award,...
The Centers for Disease Control and Prevention (CDC) awarded a single award Indefinite Delivery Contract to Glaxosmithkline, LLC, a pharmaceutical company, to procure pediatric influenza vaccines for the 2022-2023 season. The contract has a potential value of $168,590,000 and a period of performance from the date of award through February 28, 2023. The original solicitation sought between 100 doses and 50 million doses of pediatric influenza vaccine to be delivered to CDC distribution centers in...
This indefinite delivery contract was awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to provide pediatric flu vaccines for the 2020-2021 season. The contract has a potential value of $140.25 million and was awarded to Glaxosmithkline, LLC on January 7, 2020, with an ordering period through February 28, 2021. The original solicitation sought proposals to supply between 60-80 million doses of pediatric flu vaccines for nationwide delivery....
The federal contract IDV award to Glaxosmithkline, LLC is for the supply of pediatric influenza vaccines to the Centers for Disease Control and Prevention (CDC) for distribution to immunization programs under the Section 317(j) Public Health Service Act and Vaccines for Children program. The single-award contract has a ceiling value of $161,025,000 and a period of performance from December 31, 2020 to February 28, 2022. The contract was issued in response to a CDC solicitation for a minimum...
The Indefinite Delivery Contract awarded by the Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh provides adult flu vaccines for the 2023-2024 period. Glaxosmithkline, LLC was awarded a multiple award contract with a potential value of $13.9 million to deliver flu vaccines through February 2028 under associated task orders or price lists. The solicitation aimed to procure adult flu vaccines to support the Centers for Disease Control and Prevention's...
This Indefinite Delivery Contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC) to the pharmaceutical company Glaxosmithkline, LLC to provide pediatric influenza vaccines for the 2024-2025 timeframe. The contract has a ceiling value of $182,592,000 and a period of performance through February 28, 2025. Glaxosmithkline, a foreign-owned for-profit organization, has extensive experience as a prime contractor providing a range of pharmaceutical products and services to...
This indefinite delivery contract was awarded by the Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh to provide pediatric flu vaccines for 2023-2024. Astrazeneca Pharmaceuticals LP is the prime contractor for this multiple-award contract with a potential value of $58.53M. The contract aims to procure pediatric flu vaccines through a series of task orders against an established price list. As the lead federal agency for public health emergency...